Angioplasty Balloons Market size to hit $5.5 Billion by 2035 | Top companies include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, B. Braun Melsungen AG, Cardinal Health (Cordis)

Market Outlook and Forecast

The angioplasty balloons market is undergoing a period of steady expansion driven by the rising global burden of cardiovascular diseases, technological advancements in minimally invasive procedures, and increasing adoption of image-guided interventions. As healthcare systems prioritize better patient outcomes, faster recovery, and cost-effective treatments, angioplasty balloons continue to be integral to modern interventional cardiology.

According to recent assessments, the global angioplasty balloons market is valued at USD 3.6 billion in 2025 and is expected to reach USD 5.5 billion by 2035, growing at a CAGR of 4.1% from 2026 to 2035. The sustained growth highlights the shift toward rapid, precision-based cardiovascular care and the expanded use of advanced balloon technologies in both coronary and peripheral interventions.

Market expansion is further propelled by the increasing prevalence of chronic conditions such as hypertension, diabetes, and obesity - all major contributors to arterial blockages. Growing preference for minimally invasive angioplasty procedures over traditional bypass surgeries also supports long-term demand, especially in aging populations with high susceptibility to cardiac disorders.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-8030

Regional Performance Highlights

North America continues to lead the angioplasty balloons market, projected to hold 42.5% share by 2035. Strong clinical adoption of drug-coated balloons (DCBs), favorable reimbursement policies, and widespread availability of catheterization labs are key drivers. The U.S. market benefits from high interventional cardiology procedure volumes and rapid incorporation of next-generation devices approved through FDA pathways.

Europe remains a major hub for cardiovascular device innovation, supported by stringent regulatory frameworks and well-established public health infrastructure. Countries such as Germany, Italy, France, and the UK are seeing robust uptake of specialty balloons due to rising peripheral artery disease cases and strong clinician preference for DCB therapies. Growth in outpatient angioplasty procedures, supported by ASC-centric healthcare models, continues to elevate market adoption across Western Europe.

Asia Pacific is emerging as the most dynamic region, driven by an expanding patient pool, increased healthcare spending, and rapid improvements in hospital infrastructure. China, India, Japan, and South Korea are witnessing significant procedural growth due to rising cardiovascular disease prevalence and broader access to cardiac interventions. Growing medical tourism, higher investment in catheterization labs, and an expanding network of private hospitals are further accelerating demand for angioplasty balloons.

➤ Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Angioplasty Balloons Market Report Overview here: https://www.researchnester.com/reports/angioplasty-balloons-market/8030

Market Segmentation

The market is characterized by strong demand from hospitals and ambulatory surgical centers (ASCs), which together account for 78.6% of procedural utilization during the forecast tenure. Hospitals remain the primary setting for complex coronary and peripheral interventions, while ASCs are gaining momentum owing to reduced costs, shorter wait times, and faster recovery pathways.

On the basis of application, the coronary angioplasty segment is expected to hold 65.4% share by 2035, driven by the rising incidence of coronary artery disease and increasing preference for minimally invasive stent-free treatments. Drug-coated, scoring, and cutting balloons are witnessing high demand across both de novo lesions and in-stent restenosis management. Non-vascular applications-such as gastrointestinal and urological dilation-are also growing steadily, enabled by increasingly versatile balloon catheter designs.

➤ Explore the complete Angioplasty Balloons Market forecast and regional insights in our detailed report. Download our sample report here → https://www.researchnester.com/sample-request-8030

Top Market Trends

1. Rapid Advancements in Drug-Coated and Specialty Balloon Technologies

Technological innovation remains at the center of the angioplasty balloons market. Drug-coated balloons (DCBs) have gained widespread clinical acceptance for treating in-stent restenosis and peripheral arterial disease. Manufacturers are investing in advanced drug delivery matrices, improved coating durability, and optimized balloon compliance to enhance therapeutic outcomes.

Recent developments include advanced paclitaxel-coated and sirolimus-coated balloon platforms designed to reduce restenosis rates while ensuring controlled drug release. Several global firms are expanding their product portfolios with scoring balloons and high-pressure balloons capable of treating complex, calcified lesions where conventional balloons struggle.

2. Growing Preference for Minimally Invasive Cardiovascular Interventions

Shifts in patient and clinician preferences toward minimally invasive, catheter-based treatments are significantly boosting demand for angioplasty balloons. These procedures ensure smaller incisions, reduced hospital stays, lower complication risks, and faster recovery. Increasing adoption of image-guided angioplasty procedures has also enhanced precision and clinical safety.

The expansion of radial access interventions-favored for reduced bleeding risks and improved patient comfort-is accelerating procedural volumes. Emerging economies are particularly benefitting from expanded insurance coverage for angioplasty and broader availability of interventional cardiology training programs.

3. Digitalization and Integration of Smart Navigation Systems

The digital transformation of cardiovascular care is introducing advanced tools such as AI-driven imaging, robotic catheter guidance, and real-time navigation systems. These technologies increase procedural accuracy and may reduce operator fatigue and variability.

Several companies have launched platforms integrating high-resolution intravascular imaging (IVUS, OCT) with balloon angioplasty systems - helping clinicians visualize plaque composition and optimize balloon selection. Smart pressure monitoring technologies are further supporting consistent inflation control and reduced procedural errors.

4. Rising Focus on Sustainability and Eco-Design

Sustainability initiatives are gradually gaining traction within the cardiovascular device sector. Manufacturers are exploring recyclable materials, low-waste production methods, and eco-friendly packaging. Hospitals and procurement bodies are increasingly considering environmental impact within their device purchasing criteria.

Product take-back programs, greener sterilization processes, and carbon-neutral manufacturing commitments are among the emerging trends shaped by global ESG expectations.

➤ Unlock detailed analysis of key market trends transforming hybrid mobility. Get your sample report → https://www.researchnester.com/sample-request-8030

Recent Company Developments

The angioplasty balloons market has seen active product innovation, strategic mergers, and regulatory advancements over the past 12 months. Key players and emerging innovators include:

1. Medtronic plc - Expanded its cardiovascular solutions portfolio with the launch of next-generation drug-coated balloons for peripheral arterial disease across select international markets.

2. Boston Scientific Corporation - Introduced new sirolimus-coated balloons designed to address complex coronary lesions and enhance long-term vessel patency.

3. Abbott Laboratories - Announced development initiatives around image-guided angioplasty platforms integrating OCT imaging for real-time visualization.

4. B. Braun Melsungen AG - Expanded manufacturing capabilities for cardiovascular catheters in Europe to meet rising procedural demand.

5. Terumo Corporation - Launched a high-pressure scoring balloon system in Asia aimed at managing calcified lesions with greater precision.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-8030

Related News -
https://www.linkedin.com/pulse/can-emerging-therapies-redefine-gonorrhea-treatment-b4jcf
https://www.linkedin.com/pulse/why-clinical-disorder-treatment-market-becoming-global-wvfrf

Contact Data

AJ Daniel
Corporate Sales, USA
Research Nester
77 Water Street 8th Floor, New York, 10005
Email: info@researchnester.com
USA Phone: +1 646 586 9123
Europe Phone: +44 203 608 5919

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.